On 4/3/25, FormFactor Inc (NASDAQ: FORM) stock suffered a major decline of -12.1%, closing at $25.25. Moreover, above average trading volume at 120% of normal accompanied the decline. Relative to the market the stock has […]
Universal Display Corporation (NASDAQ: OLED) stock suffered a major decline of -15.4% on 4/3/25. The shares closed at $117.52. Moreover, unusually high trading volume at 183% of normal accompanied the decline. The stock has declined […]
The Estee Lauder Cos Inc (NYSE: EL) stock closed at $58.19 on 4/3/25 after a major decline of -15.4%. Moreover, trading volume in this decline was exceptionally high at 267% of normal. The stock has […]
Aehr Test Systems (NASDAQ: AEHR) stock closed at $6.84 on 4/3/25 after a major decline of -12.7%. Trading volume in this decline was normal. The stock has declined -23.0% during the last week and has […]
For its second fiscal quarter (ending February 28), Franklin Covey Co. (NYSE: FC) has reported a -214% decline in E.P.S. from $0.07 a year ago to $-0.08 in the current quarter. For the latest four […]
On 4/2/25, Vishay Precision Group Inc (NYSE: VPG) stock enjoyed a major increase of 20.2%, closing at $28.25. Moreover, trading volume in this advance was exceptionally high at 1099% of normal. Relative to the market […]
Ocular Therapeutix Inc (NASDAQ: OCUL) stock suffered a major decline of -10.8% on 4/1/25. The shares closed at $6.54. Moreover, above average trading volume at 138% of normal accompanied the decline. The stock has been […]
TechTarget Inc (NASDAQ: TTGT) stock suffered a major decline of -13.8% on 4/1/25. The shares closed at $12.76. Moreover, exceptionally high trading volume at 210% of normal accompanied the decline. Relative to the market the […]
On 3/31/25, bluebird bio Inc (NASDAQ: BLUE) stock enjoyed a major increase of 19.6%, closing at $4.88. Moreover, exceptionally high trading volume at 797% of normal accompanied the advance. The stock has been extremely weak […]
Recent meaningful negative changes in fundamentals have impacted Theravance Biopharma Inc (NASDAQ: TBPH): the stock’s power rating fell below 50, the consensus estimate for December, 2025 decreased significantly, and the consensus estimate for December, 2026 […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research